Weill Cornell Medicine and Cornell Engineering are launching Engineering Innovations in Medicine, an initiative that will form unconventional partnerships that transcend academic disciplines to find solutions for such diseases as Alzheimer’s...
Read more
By analyzing key enzymes in a new way, an international team led by researchers at Weill Cornell Medicine has discovered how a well-known signaling molecule can either stimulate or suppress tumor growth depending on where it’s produced. The work...
Read more
An advanced software tool for analyzing DNA sequences from tumor samples has uncovered likely new cancer-driving genes, in a study led by Weill Cornell Medicine researchers. In the study, published Sept. 26 in Nature Communications, the...
Read more
A collaboration between Weill Cornell Medicine scientists and other leaders in Alzheimer’s disease research has revealed widespread metabolic changes in the brains of individuals with Alzheimer’s disease. The findings could lead to the...
Read more
USF Health, Weill Cornell Medicine Earn Inaugural Funding in NIH’s Newly Launched Bridge2AI Initiative, will Create Artificial Intelligence Platform for Using Voice to Diagnose Disease. As one of four projects funded by NIH’s Bridge2AI, this...
Read more
Dear Members of the Englander Institute, I hope you were able to take some time off this summer and relax with friends and family members, and hopefully recharge for a productive autumn. As you’ll see below, members of the EIPM had a very...
Read more
Weill Cornell Medicine investigators have identified definitive biological links between African ancestry and disease processes that affect an aggressive cancer type called triple-negative breast cancer (TNBC). Their analysis of TNBC tumors from...
Read more
Your Doppelgänger Is Out There and You Probably Share DNA With Them That person who looks just like you is not your twin, but if scientists compared your genomes, they might find a lot in common. By Kate Golembiewski Aug. 23, 2022 Charlie Chasen...
Read more
Researchers Identify the Target of Immune Attacks on Liver Cells in Metabolic Disorders When fat accumulates in the liver, the immune system may assault the organ. A new study from Weill Cornell Medicine researchers identifies the molecule that...
Read more
Novel Technique Provides Insights into Lung Pathology in COVID-19 Investigators at Weill Cornell Medicine and NewYork-Presbyterian have used advanced technology and analytics to map, at single-cell resolution, the cellular landscape of diseased...
Read more
There is considerable variation in the management of mantle cell lymphoma across different clinical settings, and some strategies do not always conform with what might be expected, according to an analysis by investigators from Weill Cornell...
Read more
Weill Cornell Medicine and New York Genome Center researchers, in collaboration with Oxford Nanopore Technologies, have developed a new method to assess on a large scale the three-dimensional structure of the human genome, or how the genome...
Read more